Xencor | XNCR - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Biogen USD 403.9M 45.4M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Cytokinetics USD 20.51M 4.2M 2026-06
GlaxoSmithKline GBP 14.34B 7M 2026-06
J&J USD 9.22B 1.24B 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
MacroGenics USD 3.44M 845K 2026-06
Merck USD 3.83B 36M 2026-06
Novartis USD 4.26B 64M 2026-06
Pfizer USD 4.58B 75M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Xencor USD 12.65M 4.73M 2026-06